wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38266308-009D9194-340F-4CD1-9625-7B9F6B863DF2
Q38266308-009D9194-340F-4CD1-9625-7B9F6B863DF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38266308-009D9194-340F-4CD1-9625-7B9F6B863DF2
Personalized treatment of EGFR mutant and ALK-positive patients in NSCLC.
P2860
Q38266308-009D9194-340F-4CD1-9625-7B9F6B863DF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38266308-009D9194-340F-4CD1-9625-7B9F6B863DF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
03bd24e392e76220be3347aaecddb3d38297b33b
P2860
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors.